Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 195

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer

Open access
Pasero, Christine, Gravis, Gwenaëlle, Granjeaud, Samuel, Guerin, Mathilde, Thomassin-Piana, Jeanne, Rocchi, Palma, Salem, Naji, Walz, Jochen, Moretta, Alessandro, Olive, Daniel · 2015 · Oncotarget

Abstract

// Christine Pasero 1,3 , Gwenaëlle Gravis 3 , Samuel Granjeaud 1,3 , Mathilde Guerin 1,3 , Jeanne Thomassin-Piana 3 , Palma Rocchi 1,3 , Naji Salem 3 , Jochen Walz 3 , Alessandro Moretta 4 and Daniel Olive 1,2,3 1 Centre de Recherche en Cancérologie de Marseille, Inserm, Marseille, France 2 Aix Marseille Université, Marseille, France 3 Institut Paoli-Calmettes, Marseille, France 4 Dipartimento di Medicina Sperimentale (D.I.ME.S.), Università di Genova, Genova, Italy Correspondence to: Daniel Olive, email: // Christine Pasero, email: // Keywords : natural killer cells, prostate cancer, metastases, survival, castration resistance Received : December 21, 2014 Accepted : April 10, 2015 Published : April 29, 2015 Abstract Clinical outcome of patients with metastatic prostate cancer (mPC) at diagnosis is heterogeneous and unpredictable; thus alternative treatments such as immunotherapy are investigated. We retrospectively analyzed natural killer (NK) cells by flow cytometry in peripheral blood from 39 mPC patients, with 5 year-follow-up, and their correlation with time to castration resistance (TCR) and overall survival (OS). In parallel, NK functionality was carried out against prostate tumor cell lines, analyzed for the expression of NK cell ligands, to identify the receptors involved in PC recognition. NK cells from patients with longer TCR and OS displayed high expression of activating receptors and high cytotoxicity. The activating receptors NKp30 and NKp46 were the most obvious predictive markers of OS and TCR in a larger cohort of mPC patients (OS: p = 0.0018 and 0.0009; TCR: p = 0.007 and < 0.0001 respectively, log-rank test). Importantly, blocking experiments revealed that NKp46, along with NKG2D and DNAM-1 and, to a lesser extent NKp30, were involved in prostate tumor recognition by NK cells. These results identify NK cells as potential predictive biomarkers to stratify patients who are likely to have longer castration response, and pave the way to explore therapies aimed at enhancing NK cells in mPC patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.3965

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 195

Metadata

Authors
Pasero, C., Gravis, G., Granjeaud, S., Guerin, M., Thomassin-Piana, J., Rocchi, P., Salem, N., Walz, J., Moretta, A., & Olive, D.
Venue
Oncotarget
Published
2015-04-29
Volume
6
Issue
16
Pages
14360-14373
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1671560425
Cited by
195
References
4
FWCI
5.22
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.